Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
36 participants
INTERVENTIONAL
2012-07-10
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary objectives are the following:
* assess the improvement of daily activity at several times : 2, 6 and 12 months after the beginning of a pulmonary rehabilitation program
* assess the improvement of exercise capacity by tests used in medical practice
* assess the correlation between daily activity and exercise capacity
* assess the improvement of dyspnea
* assess the improvement of quality of life and psychological state
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Different Exercise Training on Exercise Capacity and Fatigue in Patients With Sarcoidosis
NCT05368883
Feasibility & Effect of a Tele-rehabilitation Program in Pulmonary Sarcoidosis Pulmonary Sarcoidosis
NCT03914027
Pulmonary Rehabilitation in Non-Cystic Fibrosis Bronchiectasis
NCT02823587
Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF)
NCT03717012
Long-term Airway Clearance Therapy in Non-cystic Fibrosis Bronchiectasis
NCT02324855
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The secondary objectives are the following :
* assess the improvement of daily activity at several times : 2, 6 and 12 months after the beginning of a pulmonary rehabilitation program
* assess the improvement of exercise capacity by tests used in medical practice
* assess the correlation between daily activity and exercise capacity
* assess the improvement of dyspnea
* assess the improvement of quality of life and psychological state
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulmonary rehabilitation
Sarcoidosis patients will realize a pulmonary rehabilitation program
Pulmonary rehabilitation program
Pulmonary rehabilitation program should follow ATS/ERS Guidelines (2006)
Controls
Sarcoidosis patients who do not achieve a respiratory rehabilitation program but will have physical activity counseling.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulmonary rehabilitation program
Pulmonary rehabilitation program should follow ATS/ERS Guidelines (2006)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No hospitalization for respiratory distress in the 3 months preceding the inclusion
* Dyspnea on exertion
* Age over 18 years
Exclusion Criteria
* Inability to give written consent to the study
* Refusal of contraception in women of childbearing age
* Inability to participate in the entire study
* No cover by the social security system
* Inability to perform self-questionnaires etude
The trial does not include special populations include:
* Pregnant women
* Breastfeeding women
* People in emergencies
* Persons unable to consent
* Persons deprived of liberty
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benoît WALLAERT, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Clinique des Maladies Respiratoires, CHRU de Lille
Frédéric BART, MD
Role: PRINCIPAL_INVESTIGATOR
Service de Pneumologie, CH Béthune
Dominique VALEYRE, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Service de pneumologie, Hôpital Avicenne AP-HP
Dominique ISRAEL-BIET, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Service de Pneumologie, Hôpital européen Georges Pompidou. AP-HP
Jean AMOURETTE, MD
Role: PRINCIPAL_INVESTIGATOR
Service de Pneumologie, CH Arras
Yves PACHECO, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Lyon Sud
Vincent COTTIN, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Service de Pneumologie, Hôpital Louis Pradel, Lyon
Martine REYNAUD-GAUBERT, MD PhD
Role: PRINCIPAL_INVESTIGATOR
CHU Nord, APHM Marseille
Sylvie LEROY, MD
Role: PRINCIPAL_INVESTIGATOR
Service de Pneumologie, Hôpital Pasteur - Pavillon H, CHU de Nice
Gaëtan DESLEE, MD
Role: PRINCIPAL_INVESTIGATOR
Hôpital Maison Blanche, CHU de Reims
François STEENHOUWER, MD
Role: PRINCIPAL_INVESTIGATOR
Service de Pneumologie, Hôpital Victor Provo, Roubaix
Alain DIDIER, MD
Role: PRINCIPAL_INVESTIGATOR
Clinique des Voies Respiratoires, Hôpital Larrey, Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique des Maladies Respiratoires, CHRU de LILLE
Lille, Nord, France
Service de Pneumologie, CH Béthune
Béthune, Pas De Calais, France
Service de Pneumologie, CH Arras
Arras, , France
Service de pneumologie, Hôpital Avicenne AP-HP
Bobigny, , France
CHU Nord, APHM Marseille
Marseille, , France
Service de Pneumologie, Hôpital Pasteur - Pavillon H, CHU de Nice
Nice, , France
Service de Pneumologie, Hôpital européen Georges Pompidou. AP-HP
Paris, , France
Centre Hospitalier Lyon Sud
Pierre-Bénite, , France
Hôpital Maison Blanche, CHU de Reims
Reims, , France
Service de Pneumologie, Hôpital Victor Provo
Roubaix, , France
Clinique des Voies Respiratoires, Hôpital Larrey
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wallaert B, Kyheng M, Labreuche J, Stelianides S, Wemeau L, Grosbois JM. Long-term effects of pulmonary rehabilitation on daily life physical activity of patients with stage IV sarcoidosis: A randomized controlled trial. Respir Med Res. 2020 Mar;77:1-7. doi: 10.1016/j.resmer.2019.10.003. Epub 2019 Oct 28.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-A00347-36
Identifier Type: OTHER
Identifier Source: secondary_id
2011_23/1917
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.